ProShare Advisors’s Vir Biotechnology VIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$195K Sell
21,768
-1,757
-7% -$14K ﹤0.01% 1590
2025
Q4
$142K Buy
23,525
+1,705
+8% +$10.2K ﹤0.01% 1808
2025
Q3
$125K Sell
21,820
-3,285
-13% -$16.8K ﹤0.01% 1804
2025
Q2
$127K Sell
25,105
-2,486
-9% -$13.3K ﹤0.01% 1824
2025
Q1
$179K Sell
27,591
-5,972
-18% -$53.1K ﹤0.01% 1721
2024
Q4
$246K Buy
33,563
+6,767
+25% +$53.4K ﹤0.01% 1768
2024
Q3
$201K Buy
26,796
+5,441
+25% +$47.3K ﹤0.01% 1730
2024
Q2
$190K Sell
21,355
-5,037
-19% -$48.3K ﹤0.01% 1540
2024
Q1
$267K Buy
26,392
+2,035
+8% +$20.7K ﹤0.01% 1501
2023
Q4
$245K Buy
24,357
+2,789
+13% +$25.5K ﹤0.01% 1522
2023
Q3
$202K Buy
21,568
+13
+0.1% +$185 ﹤0.01% 1458
2023
Q2
$529K Buy
21,555
+1,693
+9% +$42.5K ﹤0.01% 921
2023
Q1
$462K Sell
19,862
-3,841
-16% -$98.2K ﹤0.01% 947
2022
Q4
$600K Buy
23,703
+1,288
+6% +$31.6K ﹤0.01% 879
2022
Q3
$431K Buy
22,415
+619
+3% +$15.7K ﹤0.01% 965
2022
Q2
$556K Sell
21,796
-4,843
-18% -$113K ﹤0.01% 905
2022
Q1
$685K Sell
26,639
-6,759
-20% -$200K ﹤0.01% 1097
2021
Q4
$1.4M Sell
33,398
-3,941
-11% -$154K ﹤0.01% 879
2021
Q3
$1.63M Sell
37,339
-4,018
-10% -$174K ﹤0.01% 764
2021
Q2
$1.96M Buy
41,357
+8,126
+24% +$369K 0.01% 730
2021
Q1
$1.7M Buy
33,231
+536
+2% +$28.9K 0.01% 753
2020
Q4
$876K Buy
32,695
+25,010
+325% +$813K ﹤0.01% 945
2020
Q3
$264K Buy
7,685
+1,259
+20% +$54.2K ﹤0.01% 1264
2020
Q2
$263K Buy
+6,426
New +$216K ﹤0.01% 1300

Other funds holding VIR